One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Rosalind G. Brewer net worth and biography

Rosalind Brewer Biography and Net Worth

CEO of Walgreens Boots Alliance

Rosalind (Roz) Brewer joined Walgreens Boots Alliance, Inc. as Chief Executive Officer in March 2021. She also is a Director on WBA’s Board. Ms. Brewer most recently served as Chief Operating Officer and Group President at Starbucks from October 2017 to January 2021. Prior to Starbucks, she served as President and Chief Executive Officer of Sam’s Club, a membership-only retail warehouse club and division of Walmart, Inc., from February 2012 to February 2017. Ms. Brewer previously held several executive leadership positions with Walmart beginning in 2006.

Prior to joining Walmart, she served as President of Global Nonwovens Division for Kimberly-Clark Corporation, a global health and hygiene products company, from 2004 to 2006, and held various management positions at Kimberly-Clark beginning in 1984.

She currently serves as a Board Member of VillageMD, World Business Chicago, Business Roundtable and the Smithsonian’s National Museum of African-American History and Culture. Ms. Brewer formerly served on the board of directors for Starbucks, Amazon, Lockheed Martin Corporation and Molson Coors Brewing Company. She is Chair Emerita of the Board of Trustees for Spelman College, where she did her undergraduate work. She served on the college’s board for 17 years. Brewer is currently ranked #7 on Fortune’s 50 Most Powerful Women in Business and was named one of the 25 most influential women by the Financial Times in 2021.

What is Rosalind G. Brewer's net worth?: The estimated net worth of Rosalind G. Brewer is at least $6.50 million as of March 29th, 2023. Ms. Brewer owns 369,945 shares of Walgreens Boots Alliance stock worth more than $6,499,934 as of April 25th. This net worth estimate does not reflect any other investments that Ms. Brewer may own. Learn More about Rosalind G. Brewer's net worth.
How do I contact Rosalind G. Brewer?: The corporate mailing address for Ms. Brewer and other Walgreens Boots Alliance executives is 108 Wilmot Road, Deerfield IL, 60015. Walgreens Boots Alliance can also be reached via phone at (847) 315-3700 and via email at [email protected]. Learn More on Rosalind G. Brewer's contact information.
Has Rosalind G. Brewer been buying or selling shares of Walgreens Boots Alliance?: Rosalind G. Brewer has not been actively trading shares of Walgreens Boots Alliance during the past quarter. Most recently, on Wednesday, March 29th, Rosalind G. Brewer bought 10,000 shares of Walgreens Boots Alliance stock. The stock was acquired at an average cost of $33.95 per share, with a total value of $339,500.00. Following the completion of the transaction, the chief executive officer now directly owns 369,945 shares of the company's stock, valued at $12,559,632.75. Learn More on Rosalind G. Brewer's trading history.
Who are Walgreens Boots Alliance's active insiders?: Walgreens Boots Alliance's insider roster includes Kevin Ban (EVP), Ornella Barra (COO), Rosalind Brewer (CEO), John Driscoll (EVP), Richard Gates (SVP), Valerie Jarrett (Director), Marco Pagni (CAO), Nancy Schlichting (Director), Timothy Wentworth (CEO), and Kathleen Wilson-Thompson (EVP). Learn More on Walgreens Boots Alliance's active insiders.
Are insiders buying or selling shares of Walgreens Boots Alliance?: During the last twelve months, Walgreens Boots Alliance insiders bought shares 5 times. They purchased a total of 28,628 shares worth more than $659,610.88. During the last twelve months, insiders at the pharmacy operator sold shares 2 times. They sold a total of 16,209 shares worth more than $371,017.45. The most recent insider tranaction occured on April, 11th when Director Inderpal S Bhandari bought 3,000 shares worth more than $54,150.00. Insiders at Walgreens Boots Alliance own 17.4% of the company. Learn More about insider trades at Walgreens Boots Alliance.
Information on this page was last updated on 4/11/2024.

Rosalind G. Brewer Insider Trading History at Walgreens Boots Alliance

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/29/2023	Buy	10,000	$33.95	$339,500.00	369,945

Rosalind G. Brewer Buying and Selling Activity at Walgreens Boots Alliance

Walgreens Boots Alliance Company Overview

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Today's Range

Now: $17.57

$17.53

$17.89

50 Day Range

MA: $20.19

$17.59

$22.31

2 Week Range

Now: $17.57

$17.51

$35.38

Volume

4,972,106 shs

Average Volume

13,867,955 shs

Market Capitalization

$15.16 billion

P/E Ratio

N/A

Dividend Yield

5.54%

Beta

0.73

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

Get the name of the stock here >>>